TP53 and B-cell chronic lymphocytic leukemia: In recent years, in addition to the known alterations in DNA-repair genes (TP53 and ATM), next generation sequencing has identified new somatic mutations (NOTCH1, SF3B1, BIRC3, POT1, MYD88) with predicted functional relevance in CLL [3–6].